chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 60-year-old male patient received BNT162b2 (BNT162B2), on 02May2022 at 17:00 as dose 4 (booster), single (Lot number: FJ4989) at the age of 59 years, in left arm for covid-19 immunization; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown) and as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunization. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Positive, notes: Tested positive, took paxlovid; (04Oct2022) Negative, notes: tested negative 48 hours apart on day 4 of treatment,; (10Oct2022) Positive, notes: then tested positive again with symptoms of same severity on 10Oct. Therapeutic measures were taken as a result of drug ineffective, covid-19.
Case number PHEH2012US003161, is an initial spontaneous report received from a nurse on 02 Feb 2012 and with a follow up received on 27 Feb 2012. This case refers to 22-years-old male patient. The patient's medical history included of scoliosis and hernia, allergic to BACTRIM, AUGMENTIN and CT contrast. The patient was received only Men A lyophilized conjugate component of MENVEO vaccine (batch number: M10035), that was reconstituted with a sterile water instead of Men C, Y, W-135 liquid conjugate, intramuscularly into his left deltoid on 02 Feb 2012. No adverse reaction had occurred following this administration error. Later the patient was vaccinated with full product. Follow up information received from a nurse on 27 Feb 2012: Updated date of vaccination, medical history and description of the event.
Female patient waiting in observation area for 15 minutes requested a bottle of water, notes that her throat feels tight and she is not sure of it is from nerves, observed for several minutes and vitals taken within normal limits. Patient continues to complain of throat tightness, lead clinician notified. Decision to administer epi/ Benadryl as per protocol. patient in no active distress, skin warm, dry, respirations without effort, color full. Epinephrine/ Benadryl administered to right deltoid. Vital sign continued to be stable, Emergency Medical Services activated, patient complain of heart pounding, lightheadedness, and shakiness post treatment, but throat and tightness has resolved. vital sign continued to be stable, ems arrived, report and endorsed to crew at 1:58 pm. Patient ambulatory, alert, skin warm, dry when transferred to emergency medical service.
Baby was born, unrelated to this incident. Aug 21 I began to have indigestion. Progressed overnight and began vomiting morning of August 22. Began to experience cramping pains. Went to urgent care and was told to go to the ER for possible appendicitis. Had CT scan which confirmed this. I had surgery that night at 7:00pm and appendix was removed.
Patient received the Covid-19 vaccine (Pfizer). He reports symptoms of  "something in my throat", was not present prior to vaccine.  "Hard to swallow my spit".  Patient calm, not in distress.   1540 -  Given water, able to drink. BP 130/90, 96% RA, HR 89 RR 20.  1550 - benadryl x 1 BP 130/84, 96% RA, HR 90, 20 RR  1555 - throat feeling better 128/82, 96% RA, HR 100, 20 RR  1600 - "a lot better" 128/82, 96%, HR 80, 16 RR.  Treatment/intervention:   water, 25 mg IM benadryl
Severe chills, weak, shaky, head pounding and heart racing. Body is sore from the chills
SORE THROAT, LOSS OF TASTE AND SMELL, FEVER SHORTNESS OF BREATH
fatigue, arm tender, headache, pain in arm, lost range of motion, took, advil, tylenol, aleve, went to urgent care on Thursday...given muscle relaxer
Patient reported she is moving in 3 weeks and was referred for evaluation possible adverse reaction to influenza vaccine (see 2/13/2017 note). Patient advised she received her first annual flu vaccine on 9/22/2016 (FLUARIX by SKB lot#CS979) am during mass shot-ex (was after breakfast). Less than 1 hour later while in class her neck was itchy and a classmate advised it was red. She removed her blouse shirt and noted both arms had fine red single bumps, some areas in grouping with pus like heads that also itched. Her instructor sent her immediately to medical even though she advised she had no chest pain, difficulty breathing, angioedema or any other issues. Once at medical, she recalls a nurse advising her to "apply a topical cream to rash and take a bath" but this visit/reaction was not documented. Patient advised she contacted her mother (a nurse) who advised some topical cream and to use BENADRYL. The reaction resolved in 2-3 days without any sequelae. This is when patient's mother advised her about family history of egg allergy is sister/father and that she may have same allergies. Patient advised she doesn't eat eggs because she dislikes them, but can eat items cooked with eggs (breads, cookies, etc...she has never had meringue pies). Patient advised she experiences a similar rash when given IVP dye with MRI, and with food allergies (red peppers, lettuce, blueberries). Patient advised she doesn't recall what she ate that day as too long ago, but has not changed dietary habits since eating all food groups prior to and since vaccinated. Patient was referred by attending MD at same clinic on 2/13/2017 who verified with nurse that this patient was seen at the clinic (nurse recalls the patient) and referred patient to hospital for further evaluation and to immunization clinic for documentation of 9/22/2016 flu vaccination.
pt recvd vax;had a shrill cry,lasted all noc p/ vax;mom could not settle pt down;was not seen by MD or did not report to MD about this;apap given x 2-3 days and stated pt was not febrile;
Patient developed fever to 101 and Local swelling and warmth over his left thigh which spread to his hip and below the knee, leading to pain, decreased range of motion of his left hip and knee and refusal to bear weight on that leg.
EDEMA 5CM X 4CM  REACTION L THIGH, REDNESS AND SWELLING  HOT WHERE DTAP WAS GIVEN
starting crying 4 1/2 hr p/vax;crying cont for approx 18hr;unable to console baby;temp ranged from 99 to 102 recommended eval by MD;mom did not take pt;
The patient was drowsy all day. Similar to a hangover; Vaccine has caused him to overthink like a Philosopher; The patient says that he is not sleeping and when he does sleep it is with his eyes open; headache; This spontaneous case was reported by a patient and describes the occurrence of SOMNOLENCE (The patient was drowsy all day. Similar to a hangover), THINKING ABNORMAL (Vaccine has caused him to overthink like a Philosopher), SLEEP DISORDER (The patient says that he is not sleeping and when he does sleep it is with his eyes open) and HEADACHE (headache) in an adult male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. ASKU and ASKU) for COVID-19 prophylaxis.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SOMNOLENCE (The patient was drowsy all day. Similar to a hangover), THINKING ABNORMAL (Vaccine has caused him to overthink like a Philosopher), SLEEP DISORDER (The patient says that he is not sleeping and when he does sleep it is with his eyes open) and HEADACHE (headache). At the time of the report, SOMNOLENCE (The patient was drowsy all day. Similar to a hangover) and HEADACHE (headache) had not resolved and THINKING ABNORMAL (Vaccine has caused him to overthink like a Philosopher) and SLEEP DISORDER (The patient says that he is not sleeping and when he does sleep it is with his eyes open) outcome was unknown.            No concomitant medication was reported. The patient received his first Moderna Covid-19 vaccine in 2020 or 2021. The patient was drowsy all day. Similar to a hangover. The patient also had pain in the head or a headache. Patient reports that the pain in his head was a 10 out of 10. The patient received his second dose of the Moderna Covid-19 vaccine and is not clear when he received the second dose of the Moderna Covid-19 vaccine. The patient does not know the lot number of the vaccine and does not remember which arm that he received his vaccine in. This caused a lot of drowsiness. The patient cannot stop thinking after he received his first vaccine. The patient was overthinking about the whole world. The patient thinks that the Moderna Covid-19 vaccine has caused him to overthink like a philosopher. The patient wonders about the clouds in the sky pollution from Smokestacks. Also mentions tobacco and alcohol in relation to being a philosopher and then the patient asked the agent to forget about it. The patient tries not to use alcohol as it causes Cirrhosis and organ damage. The patient was not sleeping and when he does sleep it was with his eyes open. The patient said that the planet looks unbelievably real. The planet looks beautiful. The patient looks at the Sun and wonders if it was another planet on fire. The patient looks at the moon and wonders if it was real. No treatment medication was reported.
Pt. Got 2nd Moderna Vaccine 1 week early. His vaccine card were different and was not caught until after he got vaccine. No ill effects for pt. thus far.
The night after vaccination the patient ran a low grade fever of 100 degrees. There was redness and swelling at the injection site. The patient started taking an NSAID to help with the fever and body aches. The following day (11/20/2017) the fever was gone and the injection site was clear, no swelling or redness. However, the redness and swelling had moved down the arm to the bicep. The patient reports it encompasses an area of 3 inches by 4 inches. It is sore but not warm to the touch. Patient is continuing the NSAID as directed.
pt felt faint and passed out immediately after injection, approx 5 sec. 10:15 am BP 117/65 P: 59 O2 Sat 100% 10:16 BP 102/58 P: 74 O2 Sat 100:-Juice given once 10:20 BP 108/68 P: 70 O2 Sat 1005-pt allowed to sit up 10:25 BP 103/68 P: 80 O2 Sat 100% 10:30 BP 96/66 P: 72 O2 Sat 100%
Pt had PNEUMOVAX vaccine on 10/20/14 and began having symptoms of swelling, erythema at site, and pain to touch on 10/21/14. Pt has history of a plate and pins in right arm. Pt treated cellulitis on 10/27/14 and referred to primary physician for further evaluation and ortho patient.
DR SPOKE WITH PARENT (MOTHER) AND CHILD WAS REPORTED AS FEELING WELL WITH NO ADVERSE REACTIONS.  THE CONVERSATION WAS REPORTED ON THE FOLLOWING DAY WITHIN 24 HOURS OF THE VACCINATIONS.
Patient reports that starting Wednesday afternoon she felt "yuck". Continues to state that from Wednesday afternoon until approximately Saturday afternoon she had flu like symptoms, consisting of fever, chills, aches, muscle cramps in her legs.
This spontaneous report as received from a 78 year old female consumer with no pertinent medical history and allergy to hydralazine and COREG reporting on herself. On 01-DEC-2012, the patient was vaccinated with a dose of ZOSTAVAX (Lot # not reported). Concomitant therapies included lisinopril (manufacturer unknown) and NORVASC. The consumer reported that on 18-JAN-2013, she was admitted to hospital overnight for an episode of dizziness. Her head was spinning and she suffered from nausea. She also reported that at that time it was found her platelet count jumped to over 1 million. The patient was treated with baby aspirin per day for the adverse events. A blood work, bone marrow aspiration, MRA and brain scan were performed (results not provided). The outcome of dizziness, platelet count jumped to over 1 million, nausea and head was spinning was reported as not recovered/not resolved. Additional information has been requested.
I had a fever that was 103.6 and I had a very headache and my vision was blurry.
Flu like symptoms including sweatiness, chills, nausea, headache for 6 hours.
Initial unsolicited report received from a nurse on 07-Oct-2015. This case involves a two male patiens (age was not reported), who were vaccinated with two doses of IMOVAX via intramuscular route (manufacturer: Sanofi Pasteur, batch number: L1260-3, expiry date and site of administration were not provided) on 15-Sep (year was not provided), two doses of RABAVERT (manufacturer: other, batch number, expiry date, route and site of administration were not provided) and one dose of HRIG (manufacturer: unknown, batch number, expiry date, route and site of administration were not provided) on an unspecified date. Illness at time of vaccination and pre-existing physician diagnosed allergies, birth defects, medical conditions was unknown. Concomitant medications were not provided. On an unspecified date post vaccination, after the second Rabavert dose and prior to the Imovax dose, the patients experienced extreme lethargy, malaise, headaches and tiredness. Laboratory investigations and corrective treatment were not reported. It was reported that the patient required ER/doctor visit. The patient had not yet recovered from the above mentioned events. Documents held by sender: none.
stiff neck; a swelling that is pressing her neck, collarbone and shoulder.; swollen lymph node; The nodule feeling is thickening; nodules by neck; bad pain, hurting in neck region between neck and shoulder and collar bone; sore arm/soreness in arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the parent.  A 13-year-old female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 10Dec2022 as dose 3 (booster), 0.3 ml single (Batch/Lot number: unknown) at the age of 13 years intramuscular for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1 unknown manufacturer), for COVID-19 Immunization; Covid-19 vaccine (Dose 2 unknown manufacturer), for COVID-19 Immunization. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 10Dec2022, outcome "unknown", described as "sore arm/soreness in arm"; NECK PAIN (non-serious) with onset 12Dec2022, outcome "unknown", described as "bad pain, hurting in neck region between neck and shoulder and collar bone"; NODULE (non-serious) with onset 12Dec2022, outcome "unknown", described as "nodules by neck"; MUSCULOSKELETAL STIFFNESS (non-serious), outcome "unknown", described as "stiff neck"; SWELLING (non-serious), outcome "unknown", described as "a swelling that is pressing her neck, collarbone and shoulder."; LYMPHADENOPATHY (non-serious), outcome "unknown", described as "swollen lymph node"; FEELING ABNORMAL (non-serious), outcome "unknown", described as "The nodule feeling is thickening.  Additional information: Patient received the Bivalent booster dose for 12 years and up last Saturday on the evening. At the beginning she had a sore arm, however, she woke up with a stiff neck. with a swelling that is pressing her neck, collarbone and shoulder. She mentioned this is a swelling that goes beyond the stiff neck. They thought she might had slept in a bad position, but then they noticed about this swollen lymph node. Patient has soreness in arm. This was patient's 3rd one and yesterday patient getting nodules by neck, bad pain, was hurting in neck region between neck and shoulder and collar bone. Thought patient had pulled a muscle because patient was trying to not sleep on arm. The nodule feeling is thickening  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 47-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 02Nov2021 as dose 3 (booster), single (Lot number: Fg3527) at the age of 46 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Known allergies: Shellfish" (unspecified if ongoing), notes: Known allergies: Shellfish; "Known allergies: mushrooms" (unspecified if ongoing), notes: Known allergies: mushrooms; "Known allergies: bee stings" (unspecified if ongoing), notes: Known allergies: bee stings. Concomitant medication(s) included: SERTRALINE, start date: 14Oct2020. Past drug history included: Augmentin, reaction(s): "Known allergies: Augmentin". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jul2022, outcome "unknown" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of covid-19.
I had went to an eye doctor and he was worried because I had red, scaly, itchy spots close to my eye. It never spread, but the doctor told me to see a dermatologist. When I went to the dermatologist he diagnosed me with shingles and put me on some medication. I was off for a week from work.
Patient arrived at the pharmacy with daughter and another patient to receive their first doses of the Pfizer vaccine. While answering the pre-vaccine questionnaire the patient's daughter asked a question regarding first dose side effects the patient made a vague comment about have no side effects herself. I then asked the patient directly if this was their 1st dose of the vaccine and they stated that it was. After giving the vaccine I then went to report the vaccination to OSIIS  and saw that the patient had already completed a sequence of the Moderna vaccine back in JAN/FEB. I then asked the patient if they had received the Moderna vaccine already to which she admitted that she had. Patient told me she had seen in the news that it was recommended to get the other two dose series then you already had to help protect against the delta variant. As I was unsure of the recommendations in this scenario I contacted the Health Department Covid Hotline, who recommended to report the incident to VAERS. As of this writing the patient has had no side effects, but I did recommend that the patient inform her PCP that she had received 3 doses of the vaccine now.
Around 5 hours after my injection I felt chills, 6-7 hours after injection I was very tired, 12 hours after injection I had body aches and headache anc was tired, I went to sleep and woke up at 2am (15 hours after injection) and had such a high fever 102.5 body and head aches that I couldn?t sleep for 2-3 hours. Fever and pain subsided a bit by the next morning at 8am but not fully. I stayed in bed and was in and out of sleep until 1 or 2pm. Headache and bodyaches stayed with me throughout the day and fever stayed at or above 101. Around 3 o?clock I took pain medication and was able to go about my day almost as normal but with fatigue.
faint/lightheaded, numbness in lips and arm. Evaluated by EMS-Cleared
Experienced sore arm and an itchy rash at the injection site one week after covid vaccine; Experienced sore arm and an itchy rash at the injection site one week after covid vaccine; an itchy rash at the injection site one week after covid vaccine; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 50 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 25Feb2021 14:00 (Lot number: EL3247) at the age of 50 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Raynauds Syndrome" (unspecified if ongoing). Concomitant medication(s) included: NIFEDIPINE; TYLENOL. The following information was reported: PAIN IN EXTREMITY (non-serious), VACCINATION SITE RASH (non-serious) all with onset 05Mar2021 07:00, outcome "not recovered" and all described as "Experienced sore arm and an itchy rash at the injection site one week after covid vaccine"; VACCINATION SITE PRURITUS (non-serious) with onset 05Mar2021, outcome "not recovered", described as "an itchy rash at the injection site one week after covid vaccine". Therapeutic measures were not taken as a result of pain in extremity, vaccination site rash, vaccination site pruritus.  Additional information: Patient was not administered any vaccine prior to covid vaccination. Patient had not underwent for covid test after vaccination. Patient was not reported any allergy.   No follow-up attempts are possible. No further information is expected.
Within 24 hours post vax arm injection site became swollen, hot and tender. Area of redness measured 3" X 2".
190 patients (9 different lot numbers) received a vaccine past the beyond used by date; no adverse event; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date) and NO ADVERSE EVENT (no adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date) and NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date) and NO ADVERSE EVENT (no adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (190 patients (9 different lot numbers) received a vaccine past the beyond used by date).    Concomitant medication was not provided. It was unknown if patient received any other vaccines in the 4 weeks prior to COVID-19 Vaccine. Treatment information was not reported.   This case was linked to US-MODERNATX, INC.-MOD-2023-704335 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-704335:Master case